ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 102 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $48,000 | -25.0% | 36,284 | 0.0% | 0.00% | – |
| Q4 2021 | $64,000 | -23.8% | 36,284 | -5.8% | 0.00% | – |
| Q3 2021 | $84,000 | -37.8% | 38,536 | 0.0% | 0.00% | – |
| Q2 2021 | $135,000 | -64.5% | 38,536 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $380,000 | -8.0% | 38,536 | +1.1% | 0.00% | 0.0% |
| Q4 2020 | $413,000 | +8.7% | 38,112 | +3.2% | 0.00% | 0.0% |
| Q3 2020 | $380,000 | -28.2% | 36,926 | +45.9% | 0.00% | 0.0% |
| Q2 2020 | $529,000 | +72.3% | 25,312 | -19.3% | 0.00% | 0.0% |
| Q1 2020 | $307,000 | +0.3% | 31,375 | +18.2% | 0.00% | 0.0% |
| Q4 2019 | $306,000 | +157.1% | 26,535 | +21.4% | 0.00% | – |
| Q3 2019 | $119,000 | -54.2% | 21,853 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $260,000 | +145.3% | 21,853 | +8.1% | 0.00% | – |
| Q1 2019 | $106,000 | +65.6% | 20,214 | 0.0% | 0.00% | – |
| Q4 2018 | $64,000 | -47.5% | 20,214 | 0.0% | 0.00% | – |
| Q3 2018 | $122,000 | +14.0% | 20,214 | 0.0% | 0.00% | – |
| Q2 2018 | $107,000 | – | 20,214 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 6,552,068 | $14,218,000 | 8.03% |
| Versant Venture Management, LLC | 5,068,233 | $10,998,000 | 4.55% |
| K2 PRINCIPAL FUND, L.P. | 1,653,874 | $3,589,000 | 0.29% |
| RTW INVESTMENTS, LP | 7,483,757 | $16,240,000 | 0.24% |
| Avoro Capital Advisors LLC | 6,950,000 | $15,082,000 | 0.24% |
| Artal Group S.A. | 3,000,000 | $6,510,000 | 0.15% |
| ALGERT GLOBAL LLC | 231,490 | $502,000 | 0.07% |
| Virtus ETF Advisers LLC | 57,768 | $125,000 | 0.06% |
| Pinz Capital Management, LP | 53,600 | $116,000 | 0.05% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 100,000 | $217,000 | 0.05% |